A citation-based method for searching scientific literature

C Bethan Powell, Cecile Laurent, Giuseppe Ciaravino, Christine Garcia, Liz Han, Elizabeth Hoodfar, Audrey Karlea, Christine Kobelka, Jaimie Lee, Ramey D Littell, Janise Roh, Agniezka Vay, Lawrence H Kushi. Gynecol Oncol 2020
Times Cited: 5







List of co-cited articles
23 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Evaluation of a Streamlined Oncologist-Led BRCA Mutation Testing and Counseling Model for Patients With Ovarian Cancer.
Nicoletta Colombo, Gloria Huang, Giovanni Scambia, Eva Chalas, Sandro Pignata, James Fiorica, Linda Van Le, Sharad Ghamande, Santiago González-Santiago, Isabel Bover,[...]. J Clin Oncol 2018
53
100

Projecting the Supply and Demand for Certified Genetic Counselors: a Workforce Study.
Jennifer M Hoskovec, R L Bennett, M E Carey, J E DaVanzo, M Dougherty, S E Hahn, B S LeRoy, S O'Neal, J G Richardson, C A Wicklund. J Genet Couns 2018
131
80

Oncologist-led BRCA 'mainstreaming' in the ovarian cancer clinic: A study of 255 patients and its impact on their management.
Megan Rumford, Mark Lythgoe, Iain McNeish, Hani Gabra, Laura Tookman, Nazneen Rahman, Angela George, Jonathan Krell. Sci Rep 2020
13
60

Germline and Somatic Tumor Testing in Epithelial Ovarian Cancer: ASCO Guideline.
Panagiotis A Konstantinopoulos, Barbara Norquist, Christina Lacchetti, Deborah Armstrong, Rachel N Grisham, Paul J Goodfellow, Elise C Kohn, Douglas A Levine, Joyce F Liu, Karen H Lu,[...]. J Clin Oncol 2020
83
60

Implementing rapid, robust, cost-effective, patient-centred, routine genetic testing in ovarian cancer patients.
Angela George, Daniel Riddell, Sheila Seal, Sabrina Talukdar, Shazia Mahamdallie, Elise Ruark, Victoria Cloke, Ingrid Slade, Zoe Kemp, Martin Gore,[...]. Sci Rep 2016
107
60

Developing a conceptual, reproducible, rubric-based approach to consent and result disclosure for genetic testing by clinicians with minimal genetics background.
Kelly E Ormond, Miranda L G Hallquist, Adam H Buchanan, Danielle Dondanville, Mildred K Cho, Maureen Smith, Myra Roche, Kyle B Brothers, Curtis R Coughlin, Laura Hercher,[...]. Genet Med 2019
24
40


BRCA1/2 testing in newly diagnosed breast and ovarian cancer patients without prior genetic counselling: the DNA-BONus study.
Hildegunn Høberg-Vetti, Cathrine Bjorvatn, Bent E Fiane, Turid Aas, Kathrine Woie, Helge Espelid, Tone Rusken, Hans Petter Eikesdal, Wenche Listøl, Marianne T Haavind,[...]. Eur J Hum Genet 2016
44
40

National Estimates of Genetic Testing in Women With a History of Breast or Ovarian Cancer.
Christopher P Childers, Kimberly K Childers, Melinda Maggard-Gibbons, James Macinko. J Clin Oncol 2017
155
40

Oncology Clinic-Based Hereditary Cancer Genetic Testing in a Population-Based Health Care System.
Matthew Richardson, Hae Jung Min, Quan Hong, Katie Compton, Sze Wing Mung, Zoe Lohn, Jennifer Nuk, Mary McCullum, Cheryl Portigal-Todd, Aly Karsan,[...]. Cancers (Basel) 2020
9
40

New paradigms for BRCA1/BRCA2 testing in women with ovarian cancer: results of the Genetic Testing in Epithelial Ovarian Cancer (GTEOC) study.
Inga Plaskocinska, Hannah Shipman, James Drummond, Edward Thompson, Vanessa Buchanan, Barbara Newcombe, Charlotte Hodgkin, Elisa Barter, Paul Ridley, Rita Ng,[...]. J Med Genet 2016
41
40

Evaluation of Cancer-Based Criteria for Use in Mainstream BRCA1 and BRCA2 Genetic Testing in Patients With Breast Cancer.
Zoe Kemp, Alice Turnbull, Shawn Yost, Sheila Seal, Shazia Mahamdallie, Emma Poyastro-Pearson, Margaret Warren-Perry, Anthony Eccleston, Min-Min Tan, Soo Hwang Teo,[...]. JAMA Netw Open 2019
42
40

American Society of Clinical Oncology Policy Statement Update: Genetic and Genomic Testing for Cancer Susceptibility.
Mark E Robson, Angela R Bradbury, Banu Arun, Susan M Domchek, James M Ford, Heather L Hampel, Stephen M Lipkin, Sapna Syngal, Dana S Wollins, Noralane M Lindor. J Clin Oncol 2015
325
40

Mainstreamed genetic testing for women with ovarian cancer: first-year experience.
Belinda Rahman, Anne Lanceley, Rebecca S Kristeleit, Jonathan A Ledermann, Michelle Lockley, Mary McCormack, Tim Mould, Lucy Side. J Med Genet 2019
29
40

A universal genetic testing initiative for patients with high-grade, non-mucinous epithelial ovarian cancer and the implications for cancer treatment.
Erica M Bednar, Holly D Oakley, Charlotte C Sun, Catherine C Burke, Mark F Munsell, Shannon N Westin, Karen H Lu. Gynecol Oncol 2017
30
40

Mainstreamed genetic testing in ovarian cancer: patient experience of the testing process.
Laura McLeavy, Belinda Rahman, Rebecca Kristeleit, Jonathan Ledermann, Michelle Lockley, Mary McCormack, Tim Mould, Lucy Side, Anne Lanceley. Int J Gynecol Cancer 2020
6
40

The development and evaluation of a nationwide training program for oncology health professionals in the provision of genetic testing for ovarian cancer patients.
M Gleeson, M Kentwell, B Meiser, J Do, S Nevin, N Taylor, K Barlow-Stewart, J Kirk, P James, C L Scott,[...]. Gynecol Oncol 2020
9
40

PARP Inhibitors in the Management of Ovarian Cancer: ASCO Guideline.
William P Tew, Christina Lacchetti, Annie Ellis, Kathleen Maxian, Susana Banerjee, Michael Bookman, Monica Brown Jones, Jung-Min Lee, Stéphanie Lheureux, Joyce F Liu,[...]. J Clin Oncol 2020
60
40


Effect of routine assessment of specific psychosocial problems on personalized communication, counselors’ awareness, and distress levels in cancer genetic counseling practice: a randomized controlled trial.
Willem Eijzenga, Neil K Aaronson, Daniela E E Hahn, Grace N Sidharta, Lizet E van der Kolk, Mary E Velthuizen, Margreet G E M Ausems, Eveline M A Bleiker. J Clin Oncol 2014
20
40

Oncologist-led BRCA counselling improves access to cancer genetic testing in middle-income Asian country, with no significant impact on psychosocial outcomes.
Sook-Yee Yoon, Siu Wan Wong, Joanna Lim, Syuhada Ahmad, Shivaani Mariapun, Heamanthaa Padmanabhan, Nur Tiara Hassan, Shao Yan Lau, Gaik-Siew Ch'ng, Muzhirah Haniffa,[...]. J Med Genet 2022
3
66

The integration of BRCA testing into oncology clinics.
Natalie Percival, Angela George, Jennifer Gyertson, Monica Hamill, Andreia Fernandes, Emily Davies, Nazneen Rahman, Susana Banerjee. Br J Nurs 2016
34
40

Mainstreaming germline BRCA1/2 testing in non-mucinous epithelial ovarian cancer in the North West of England.
Nicola Flaum, Robert D Morgan, George J Burghel, Michael Bulman, Andrew R Clamp, Jurjees Hasan, Claire L Mitchell, Doina Badea, Sarah Moon, Martin Hogg,[...]. Eur J Hum Genet 2020
13
40

HOXB13 is a susceptibility gene for prostate cancer: results from the International Consortium for Prostate Cancer Genetics (ICPCG).
Jianfeng Xu, Ethan M Lange, Lingyi Lu, Siqun L Zheng, Zhong Wang, Stephen N Thibodeau, Lisa A Cannon-Albright, Craig C Teerlink, Nicola J Camp, Anna M Johnson,[...]. Hum Genet 2013
129
20

Breast-cancer risk in families with mutations in PALB2.
Antonis C Antoniou, Silvia Casadei, Tuomas Heikkinen, Daniel Barrowdale, Katri Pylkäs, Jonathan Roberts, Andrew Lee, Deepak Subramanian, Kim De Leeneer, Florentia Fostira,[...]. N Engl J Med 2014
503
20

CHEK2 variant I157T may be associated with increased breast cancer risk.
Outi Kilpivaara, Pia Vahteristo, Jacob Falck, Kirsi Syrjäkoski, Hannaleena Eerola, Douglas Easton, Jirina Bartkova, Jiri Lukas, Päivi Heikkilä, Kristiina Aittomäki,[...]. Int J Cancer 2004
114
20

Evaluation of Polygenic Risk Scores for Breast and Ovarian Cancer Risk Prediction in BRCA1 and BRCA2 Mutation Carriers.
Karoline B Kuchenbaecker, Lesley McGuffog, Daniel Barrowdale, Andrew Lee, Penny Soucy, Joe Dennis, Susan M Domchek, Mark Robson, Amanda B Spurdle, Susan J Ramus,[...]. J Natl Cancer Inst 2017
132
20

Patients' Medical and Psychosocial Experiences After Detection of a CDH1 Variant With Multigene Panel Testing.
Jada G Hamilton, Jessica M Long, Amanda C Brandt, Jamie Brower, Heather Symecko, Erin E Salo-Mullen, Stephanie N Christian, Tricia Harstad, Fergus J Couch, Judy E Garber,[...]. JCO Precis Oncol 2019
11
20

Germline and Somatic Mutations in Prostate Cancer for the Clinician.
Heather H Cheng, Alexandra O Sokolova, Edward M Schaeffer, Eric J Small, Celestia S Higano. J Natl Compr Canc Netw 2019
43
20

Results of multigene panel testing in familial cancer cases without genetic cause demonstrated by single gene testing.
Mev Dominguez-Valentin, Sigve Nakken, Hélène Tubeuf, Daniel Vodak, Per Olaf Ekstrøm, Anke M Nissen, Monika Morak, Elke Holinski-Feder, Arild Holth, Gabriel Capella,[...]. Sci Rep 2019
8
20

Genetic Counseling and Testing in a Community Setting: Quality, Access, and Efficiency.
Stephanie A Cohen, Angela Bradbury, Vida Henderson, Kent Hoskins, Erica Bednar, Banu K Arun. Am Soc Clin Oncol Educ Book 2019
26
20


The current state of cancer genetic counseling access and availability.
Sara Knapke, Joy Larsen Haidle, Rebecca Nagy, Sara Pirzadeh-Miller. Genet Med 2016
9
20

Hereditary diffuse gastric cancer: updated clinical guidelines with an emphasis on germline CDH1 mutation carriers.
Rachel S van der Post, Ingrid P Vogelaar, Fátima Carneiro, Parry Guilford, David Huntsman, Nicoline Hoogerbrugge, Carlos Caldas, Karen E Chelcun Schreiber, Richard H Hardwick, Margreet G E M Ausems,[...]. J Med Genet 2015
308
20

The CHEK2 I157T variant and breast cancer susceptibility: a systematic review and meta-analysis.
Chuan Liu, Ying Wang, Qing-Shui Wang, Ya-Jie Wang. Asian Pac J Cancer Prev 2012
34
20


Clinical Actionability of Multigene Panel Testing for Hereditary Breast and Ovarian Cancer Risk Assessment.
Andrea Desmond, Allison W Kurian, Michele Gabree, Meredith A Mills, Michael J Anderson, Yuya Kobayashi, Nora Horick, Shan Yang, Kristen M Shannon, Nadine Tung,[...]. JAMA Oncol 2015
216
20

The CHEK2 I157T variant and colorectal cancer susceptibility: a systematic review and meta-analysis.
Chuan Liu, Qing-Shui Wang, Ya-Jie Wang. Asian Pac J Cancer Prev 2012
23
20

Modes of delivery of genetic testing services and the uptake of cancer risk management strategies in BRCA1 and BRCA2 carriers.
T Pal, J-H Lee, A Besharat, Z Thompson, A N A Monteiro, C Phelan, J M Lancaster, K Metcalfe, T A Sellers, S Vadaparampil,[...]. Clin Genet 2014
24
20

Clinically guided genetic screening in a large cohort of italian patients with pheochromocytomas and/or functional or nonfunctional paragangliomas.
Massimo Mannelli, Maurizio Castellano, Francesca Schiavi, Sebastiano Filetti, Mara Giacchè, Luigi Mori, Viviana Pignataro, Gianpaolo Bernini, Valentino Giachè, Alessandra Bacca,[...]. J Clin Endocrinol Metab 2009
203
20


1
100

Performance of ACMG-AMP Variant-Interpretation Guidelines among Nine Laboratories in the Clinical Sequencing Exploratory Research Consortium.
Laura M Amendola, Gail P Jarvik, Michael C Leo, Heather M McLaughlin, Yassmine Akkari, Michelle D Amaral, Jonathan S Berg, Sawona Biswas, Kevin M Bowling, Laura K Conlin,[...]. Am J Hum Genet 2016
82
20

Spectrum of mutations in BRCA1, BRCA2, CHEK2, and TP53 in families at high risk of breast cancer.
Tom Walsh, Silvia Casadei, Kathryn Hale Coats, Elizabeth Swisher, Sunday M Stray, Jake Higgins, Kevin C Roach, Jessica Mandell, Ming K Lee, Sona Ciernikova,[...]. JAMA 2006
444
20

Detection of inherited mutations for breast and ovarian cancer using genomic capture and massively parallel sequencing.
Tom Walsh, Ming K Lee, Silvia Casadei, Anne M Thornton, Sunday M Stray, Christopher Pennil, Alex S Nord, Jessica B Mandell, Elizabeth M Swisher, Mary-Claire King. Proc Natl Acad Sci U S A 2010
335
20

Next-Generation Testing for Cancer Risk: Perceptions, Experiences, and Needs Among Early Adopters in Community Healthcare Settings.
Kathleen R Blazer, Bita Nehoray, Ilana Solomon, Mariana Niell-Swiller, Julie O Culver, Gwen C Uman, Jeffrey N Weitzel. Genet Test Mol Biomarkers 2015
35
20

Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma.
Samuel A Wells, Sylvia L Asa, Henning Dralle, Rossella Elisei, Douglas B Evans, Robert F Gagel, Nancy Lee, Andreas Machens, Jeffrey F Moley, Furio Pacini,[...]. Thyroid 2015
891
20

Risk of Prostate Cancer Associated With Familial and Hereditary Cancer Syndromes.
Jennifer L Beebe-Dimmer, Ashley L Kapron, Alison M Fraser, Ken R Smith, Kathleen A Cooney. J Clin Oncol 2020
17
20

Analysis of hereditary cancer syndromes by using a panel of genes: novel and multiple pathogenic mutations.
Georgios N Tsaousis, Eirini Papadopoulou, Angela Apessos, Konstantinos Agiannitopoulos, Georgia Pepe, Stavroula Kampouri, Nikolaos Diamantopoulos, Theofanis Floros, Rodoniki Iosifidou, Ourania Katopodi,[...]. BMC Cancer 2019
37
20

Candidate genetic modifiers for breast and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers.
Paolo Peterlongo, Jenny Chang-Claude, Kirsten B Moysich, Anja Rudolph, Rita K Schmutzler, Jacques Simard, Penny Soucy, Rosalind A Eeles, Douglas F Easton, Ute Hamann,[...]. Cancer Epidemiol Biomarkers Prev 2015
17
20


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.